Management of varicose veins and venous insufficiency

JAMA

Volumn 308, Issue 24, 2012, Pages 2612-2621

  Hamdan, Allen ^a,b  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AESCULUS HIPPOCASTANUM EXTRACT; ANASTROZOLE; CALCIUM; LIPOXYGENASE; MULTIVITAMIN; PANTOPRAZOLE; PHOSPHODIESTERASE; PROSTAGLANDIN SYNTHASE; ZOLEDRONIC ACID;

AESCULUS HIPPOCASTANUM; AGED; BREAST CANCER; CASE REPORT; COMPRESSION STOCKING; CONSERVATIVE TREATMENT; DEEP VEIN THROMBOSIS; EDEMA; FEMALE; HUMAN; HYPERPIGMENTATION; LIPODERMATOSCLEROSIS; PARTIAL MASTECTOMY; PHYSICAL EXAMINATION; PRIORITY JOURNAL; REVIEW; SAPHENOUS VEIN; SCLEROTHERAPY; SPIDER VEIN; ULCER; VARICOSIS; VEIN DISEASE; VEIN INSUFFICIENCY; VEIN STRIPPING;

EID: 84871496642     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2012.111352     Document Type: Review

References (107)

1. Labropoulos N. Hemodynamic changes according to the CEAP classification. Phlebolymphology. 2003;40:130-136.
2. Kistner RL, Eklof B. Classification and etiology of chronic venous disease. In: Gloviczki P, ed. Handbook of Venous Disorders: Guidelines of the American Venous Forum. 3rd ed. London, England: Hodder Arnold; 2009:37-46.
3. Raju S, Neglén P. Clinical practice: chronic venous insufficiency and varicose veins. N Engl J Med. 2009;360(22):2319-2327.
4. Bergan JJ, Schmid-Schönbein GW, Smith PD, et al. Chronic venous disease. N Engl J Med. 2006;355(5):488-498.
5. Sales CM, Rosenthal D, Petrillo KA, et al. The valvular apparatus in venous insufficiency: a problem of quantity? Ann Vasc Surg. 1998;12(2):153-155.
6. Kistner RL, Eklof B, Masuda EM. Diagnosis of chronic venous disease of the lower extremities: the "CEAP" classification. Mayo Clin Proc. 1996;71(4):338-345.
7. Ruckley CV, Evans CJ, Allan PL, et al. Telangiectasia in the Edinburgh Vein Study. Eur J Vasc Endovasc Surg. 2008;36(6):719-724.
8. Callam MJ. Epidemiology of varicose veins. Br J Surg. 1994;81(2):167-173.
9. Beebe-Dimmer JL, Pfeifer JR, Engle JS, Schottenfeld D. The epidemiology of chronic venous insufficiency and varicose veins. Ann Epidemiol. 2005;15(3):175-184.
10. Kurz X, Kahn SR, Abenhaim L, et al. Chronic venous disorders of the leg: epidemiology, outcomes, diagnosis and management. Int Angiol. 1999;18(2):83-102.
11. Lee AJ, Evans CJ, Allan PL, et al. Lifestyle factors and the risk of varicose veins. J Clin Epidemiol. 2003;56(2):171-179.
12. Laurikka JO, Sisto T, Tarkka MR, et al. Risk indicators for varicose veins in 40-to 60-year-olds in the Tampere Varicose Vein Study. World J Surg. 2002;26(6):648-651.
13. Chiesa R, Marone EM, Limoni C, Volonté M, Schaefer E, Petrini O. Demographic factors and their relationship with the presence of CVI signs in Italy: the 24-Cities Cohort Study. Eur J Vasc Endovasc Surg. 2005;30(6):674-680.
14. Cornu-Thenard A, Boivin P, Baud JM, et al. Importance of the familial factor in varicose disease. J Dermatol Surg Oncol. 1994;20(5):318-326.
15. Cogo A, Bernardi E, Prandoni P, et al. Acquired risk factors for deep-vein thrombosis in symptomatic outpatients. Arch Intern Med. 1994;154(2):164-168.
16. Sobreira ML, Maffei FH, Yoshida WB, et al. Prevalence of deep vein thrombosis and pulmonary embolism in superficial thrombophlebitis of the lower limbs. Int Angiol. 2009;28(5):400-408.
17. Hill SL, Hancock DH, Webb TL. Thrombophlebitis of the great saphenous vein - recommendations for treatment. Phlebology. 2008;23(1):35-39.
18. Heit JA, Kobbervig CE, James AH, et al. Trends in the incidence of venous thromboembolism during pregnancy or postpartum. Ann Intern Med. 2005;143(10):697-706.
19. Franks PJ, Moffatt CJ. Health related quality of life in patients with venous ulceration. Qual Life Res. 2001;10(8):693-700.
20. McGuckin M, Waterman R, Brooks J, et al. Validation of venous leg ulcer guidelines in the United States and United Kingdom. Am J Surg. 2002;183(2):132-137.
21. Ruckley CV. Socioeconomic impact of chronic venous insufficiency and leg ulcers. Angiology. 1997;48(1):67-69.
22. Van den Oever R, Hepp B, Debbaut B, Simon I. Socio-economic impact of chronic venous insufficiency. Int Angiol. 1998;17(3):161-167.
23. Carpentier PH, Cornu-Thénard A, Uhl JF, et al; Société Française de Médecine Vasculaire; European Working Group on the Clinical Characterization of Venous Disorders. Appraisal of the information content of the C classes of CEAP clinical classification of chronic venous disorders. J Vasc Surg. 2003;37(4):827-833.
24. Langer RD, Ho E, Denenberg JO, et al. Relationships between symptoms and venous disease. Arch Intern Med. 2005;165(12):1420-1424.
25. Payne SP, London NJ, Newland CJ, et al. Ambulatory venous pressure: correlation with skin condition and role in identifying surgically correctible disease. Eur J Vasc Endovasc Surg. 1996;11(2):195-200.
26. Katz ML, Comerota AJ, Kerr RP, Caputo GC. Variability of venous-hemodynamics with daily activity. J Vasc Surg. 1994;19(2):361-365.
27. Burnand KG, Whimster I, Clemenson G, et al. The relationship between the number of capillaries in the skin of the venous ulcer-bearing area of the lower legand the fall in foot vein pressure during exercise. Br J Surg. 1981;68(5):297-300.
28. Jünger M, Hahn U, Bort S, et al. Significance of cutaneous microangiopathy for the pathogenesis of dermatitis in venous congestion due to chronic venous insufficiency. Wien Med Wochenschr. 1994;144(10-11):206-210.
29. Porter JM, Moneta GL; International Consensus Committee on Chronic Venous Disease. Reporting standards in venous disease: an update. J Vasc Surg. 1995;21(4):635-645.
30. Eklöf B, Rutherford RB, Bergan JJ, et al; American Venous Forum International Ad Hoc Committee for Revision of the CEAP Classification. Revision of the CEAP classification for chronic venous disorders: consensus statement. J Vasc Surg. 2004;40(6):1248-1252.
31. O'Hare JL, Stephens J, Parkin D, Earnshaw JJ. Randomized clinical trial of different bandage regimens after foam sclerotherapy for varicose veins. Br J Surg. 2010;97(5):650-656.
32. Franks PJ, Oldroyd MI, Dickson D, et al. Risk factors for leg ulcer recurrence: a randomized trial of 2 types of compression stocking. Age Ageing. 1995;24(6):490-494.
33. Meissner MH, Gloviczki P, Bergan J, et al. Primary chronic venous disorders. J Vasc Surg. 2007;46(suppl S):54S-67S.
34. Ibegbuna V, Delis KT, Nicolaides AN, Aina O. Effect of elastic compression stockings on venous hemodynamics during walking. J Vasc Surg. 2003;37(2):420-425.
35. Motykie GD, Caprini JA, Arcelus JI, et al. Evaluation of therapeutic compression stockings in the treatment of chronic venous insufficiency. Dermatol Surg. 1999;25(2):116-120.
36. Raju S, Hollis K, Neglen P. Use of compression stockings in chronic venous disease. Ann Vasc Surg. 2007;21(6):790-795.
37. Jull AB, Mitchell N, Arroll J, et al. Factors influencing concordance with compression stockings after venous leg ulcer healing. J Wound Care. 2004;13(3):90-92.
38. Kiev J, Noyes LD, Rice JC, Kerstein MD. Patient compliance with fitted compression hosiery monitored by photoplethysmography. Arch Phys Med Rehabil. 1990;71(6):376-379.
39. Pittler MH, Ernst E. Horse chestnut seed extract for chronic venous insufficiency. Cochrane Database Syst Rev. 2006;(1):CD003230.
40. Siebert U, Brach M, Sroczynski G, Berla K. Efficacy, routine effectiveness, and safety of horsechestnut seed extract in the treatment of chronic venous insufficiency: ameta-analysis of randomized controlled trials and large observational studies. Int Angiol. 2002;21(4):305-315.
41. Simini B. Horse-chestnut seed extract for chronic venous insufficiency. Lancet. 1996;347(9009):1182-1183.
42. Gohel MS, Davies AH. Pharmacological agents in the treatment of venous disease. Curr Vasc Pharmacol. 2009;7(3):303-308.
43. Ramelet AA. Clinical benefits of Daflon 500 mg in the most severe stages of chronic venous insufficiency. Angiology. 2001;52(suppl 1):S49-S56.
44. Leach BC, Goldman MP. Comparative trial between sodium tetradecyl sulfate and glycerin in the treatment of telangiectatic leg veins. Dermatol Surg. 2003;29(6):612-614.
45. Kern P, Ramelet AA, Wutschert R, et al. Single-blind, randomized study comparing chromated glycerin, polidocanol solution, and polidocanol foam for treatment of telangiectatic leg veins. Dermatol Surg. 2004;30(3):367-372.
46. Goldman MP. Treatment of varicose and telangiectatic leg veins: doubleblind prospective comparative trial between Aethoxyskerol and Sotradecol. Dermatol Surg. 2002;28(1):52-55.
47. Guex JJ, Allaert FA, Gillet JL, Chleir F. Immediate and midterm complications of sclerotherapy. Dermatol Surg. 2005;31(2):123-128.
48. Kern P, Ramelet AA, Wütschert R, Hayoz D. Compression after sclerotherapy for telangiectasias and reticular leg veins: a randomized controlled study. J Vasc Surg. 2007;45(6):1212-1216.
49. Bäumler W, Ulrich H, Hartl A, et al. Optimal parameters for the treatment of leg veins using Nd:YAG lasers at 1064 nm. Br J Dermatol. 2006;155(2):364-371.
50. Goren G, Yellin AE. Minimally invasive surgery for primary varicose veins. Ann Vasc Surg. 1995;9(4):401-414.
51. Luebke T, Brunkwall J. Meta-analysis of transilluminated powered phlebectomy for superficial varicosities. J Cardiovasc Surg (Torino). 2008;49(6):757-764.
52. Passman MA, Dattilo JB, Guzman RJ, Naslund TC. Combined endovenous ablation and transilluminated powered phlebectomy: is less invasive better? Vasc Endovascular Surg. 2007;41(1):41-47.
53. Palfreyman SJ, Michaels JA. A systematic review of compression hosiery for uncomplicated varicose veins. Phlebology. 2009;24(suppl 1):13-33.
54. Proebstle TM, Moehler T, Herdemann S. Reduced recanalization rates of the great saphenous vein after endovenous laser treatment with increased energy dosing. J Vasc Surg. 2006;44(4):834-839.
55. Kanwar A, Hansrani M, Lees T, Stansby G. Trends in varicose vein therapy in England. Ann R Coll Surg Engl. 2010;92(4):341-346.
56. Merchant RF, Pichot O; Closure Study Group. Long-term outcomes of endovenous radiofrequency obliteration of saphenous reflux as a treatment for superficial venous insufficiency. J Vasc Surg. 2005;42(3):502-509.
57. Hamel-Desnos C, Gérard JL, Desnos P. Endovenous laser procedure in a clinic room: feasibility and side effects study of 1700 cases. Phlebology. 2009;24(3):125-130.
58. Shepherd AC, Gohel MS, Brown LC, et al. Randomized clinical trial of VNUS ClosureFAST radiofrequency ablation vs laser for varicose veins. Br J Surg. 2010;97(6):810-818.
59. Michaels JA, Campbell WB, Brazier JE, et al. Randomised clinical trial, observational study and assessment of cost-effectiveness of the treatment of varicose veins (REACTIV trial). Health Technol Assess. 2006;10(13):1-196.
60. Christenson JT, Gueddi S, Gemayel G, Bounameaux H. Prospective randomized trial comparing endovenous laser ablation and surgery for treatment of primary great saphenous varicose veins with a 2-year follow-up. J Vasc Surg. 2010;52(5):1234-1241.
61. Lurie F, Creton D, Eklof B, et al. Prospective randomized study of endovenous radiofrequency obliteration (closure procedure) vs ligation and stripping in a selected patient population (EVOLVES Study). J Vasc Surg. 2003;38(2):207-214.
62. Scheltinga MR, Wijburg ER, Keulers BJ, de Kroon KE. Conventional vs invaginated stripping of the great saphenous vein: a randomized, double-blind, controlled clinical trial. World J Surg. 2007;31(11):2236-2242.
63. Gale SS, Lee JN, Walsh ME, et al. A randomized, controlled trial of endovenous thermal ablation using the 810-nm wavelength laser and the ClosurePLUS radiofrequency ablation methods for superficial venous insufficiency of the great saphenous vein. J Vasc Surg. 2010;52(3):645-650.
64. Subramonia S, Lees T. Randomized clinical trial of radiofrequency ablation or conventional high ligation and stripping for great saphenous varicose veins. Br J Surg. 2010;97(3):328-336.
65. Fischer R, Chandler JG, De Maeseneer MG, et al. The unresolved problem of recurrent saphenofemoral reflux. J Am Coll Surg. 2002;195(1):80-94.
66. Negus D. Recurrent varicose veins: a national problem. Br J Surg. 1993;80(7):823-824.
67. Morrison C, Dalsing MC. Signs and symptoms of saphenous nerve injury after greater saphenous vein stripping: prevalence, severity, and relevance for modern practice. J Vasc Surg. 2003;38(5):886-890.
68. Munn SR, Morton JB, Macbeth WA, Mcleish AR. To strip or not to strip the long saphenous vein? a varicose veins trial. Br J Surg. 1981;68(6):426-428.
69. Cox SJ, Wellwood JM, Martin A. Saphenous nerve injury caused by stripping of the long saphenous vein. Br Med J. 1974;1(5905):415-417.
70. Critchley G, Handa A, Maw A, Harvey A, Harvey MR, Corbett CR. Complications of varicose vein surgery. Ann R Coll Surg Engl. 1997;79(2):105-110.
71. Corrales NE, Irvine A, McGuinness CL, et al. Incidence and pattern of long saphenous vein duplication and its possible implications for recurrence after varicose vein surgery. Br J Surg. 2002;89(3):323-326.
72. Jones L, Braithwaite BD, Selwyn D, et al. Neovascularisation is the principal cause of varicose vein recurrence. Eur J Vasc Endovasc Surg. 1996;12(4):442-445.
73. van Rij AM, Jones GT, Hill GB, Jiang P. Neovascularization and recurrent varicose veins. J Vasc Surg. 2004;40(2):296-302.
74. Campbell WB, Vijay Kumar A, Collin TW, et al; Randomised and Economic Analysis of Conservative and Therapeutic Interventions for Varicose veins Study. The outcome of varicose vein surgery at 10 years. Ann R Coll Surg Engl. 2003;85(1):52-57.
75. Geerts WH, Bergqvist D, Pineo GF, et al; American College of Chest Physicians. Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest. 2008;133(6) (suppl):381S-453S.
76. Dietzek AM. Endovenous radiofrequency ablation for the treatment of varicose veins. Vascular. 2007;15(5):255-261.
77. Shepherd AC, Gohel MS, Brown LC, et al. Randomized clinical trial of VNUS ClosureFAST radiofrequency ablation vs laser for varicose veins. Br J Surg. 2010;97(6):810-818.
78. Mordon SR, Wassmer B, Zemmouri J. Mathematic modeling of endovenous laser treatment (ELT). Biomed Eng Online. 2006;5:26.
79. Aremu MA, Mahendran B, Butcher W, et al. Prospective randomized controlled trial: conventional vs powered phlebectomy. J Vasc Surg. 2004;39(1):88-94.
80. Mayo DH. Treatment of varicose veins. Surg Obstet Gynecol. 1906;2:385-388.
81. Keller WL. A new method of extirpating the internal saphenous and similar veins in varicose conditions: a preliminary report. N Y Med J. 1905;82:385.
82. Babcock WW. A new operation for the extirpation of varicose veins of the leg. N Y Med J. 1907;86:153-156.
83. Helmy ElKaffas K, ElKashef O, ElBaz W. Great saphenous vein radiofrequency ablation vs standard stripping in the management of primary varicose veins. Angiology. 2011;62(1):49-54.
84. Almeida JI, Kaufman J, Göckeritz O, et al. Radiofrequency endovenous ClosureFAST vs laser ablation for the treatment of great saphenous reflux: a multicenter, single-blinded, randomized study (RECOVERY Study). J Vasc Interv Radiol. 2009;20(6):752-759.
85. Luebke T, Brunkwall J. Systematic review and meta-analysis of endovenous radiofrequency obliteration, endovenous laser therapy, and foam sclerotherapy for primary varicosis. J Cardiovasc Surg (Torino). 2008;49(2):213-233.
86. Goode SD, Chowdhury A, Crockett M, et al. Laser and radiofrequency ablation study (LARA Study): a randomised study comparing radiofrequency ablation and endovenous laser ablation (810 nm). Eur J Vasc Endovasc Surg. 2010;40(2):246-253.
87. Dwerryhouse S, Davies B, Harradine K, Earnshaw JJ. Stripping the long saphenous vein reduces the rate of reoperation for recurrent varicose veins: 5-year results of a randomized trial. J Vasc Surg. 1999;29(4):589-592.
88. Schanzer H. Endovenous ablation plus microphlebectomy/sclerotherapy for the treatment of varicose veins: single or 2-stage procedure? Vasc Endovascular Surg. 2010;44(7):545-549.
89. Fernández CF, Roizental M, Carvallo J. Combined endovenous laser therapy and microphlebectomy in the treatment of varicose veins. J Vasc Surg. 2008;48(4):947-952.
90. van den Bos R, Arends L, Kockaert M, et al. Endovenous therapies of lower extremity varicosities. J Vasc Surg. 2009;49(1):230-239.
91. Murad MH, Coto-Yglesias F, Zumaeta-Garcia M, et al. A systematic review and meta-analysis of the treatments of varicose veins. J Vasc Surg. 2011;53(5)(suppl):49S-65S.
92. Gloviczki P, Comerota AJ, Dalsing MC, et al; Society for Vascular Surgery; American Venous Forum. The care of patients with varicose veins and associated chronic venous diseases: clinical practice guidelines of the Society for Vascular Surgery and the American Venous Forum. J Vasc Surg. 2011;53(5)(suppl):2S-48S.
93. Darwood RJ, Theivacumar N, Dellagrammaticas D, et al. Randomized clinical trial comparing endovenous laser ablation with surgery for the treatment of primary great saphenous varicose veins. Br J Surg. 2008;95(3):294-301.
94. Lawrence PF, Chandra A, Wu M, et al. Classification of proximal endovenous closure levels and treatment algorithm. J Vasc Surg. 2010;52(2):388-393.
95. Theivacumar NS, Dellagrammaticas D, Beale RJ, et al. Factors influencing the effectiveness of endovenous laser ablation (EVLA) in the treatment of great saphenous vein reflux. Eur J Vasc Endovasc Surg. 2008;35(1):119-123.
96. Tisi PV, Beverley C, Rees A. Injection sclerotherapy for varicose veins. Cochrane Database Syst Rev. 2006;(4):CD001732.
97. Perrin M. Endovenous radiofrequency ablation of saphenous vein reflux. Int Angiol. 2010;29(4):303-307.
98. Figueiredo M, Araújo S, Barros N Jr, Miranda F Jr. Results of surgical treatment compared with ultrasound-guided foam sclerotherapy in patients with varicose veins. Eur J Vasc Endovasc Surg. 2009;38(6):758-763.
99. Rigby KA, Palfreyman SJ, Beverley C, Michaels JA. Surgery vs sclerotherapy for the treatment of varicose veins. Cochrane Database Syst Rev. 2004;(4):CD004980.
100. Breu FX, Guggenbichler S. European Consensus Meeting on Foam Sclerotherapy, April 4-6, 2003, Tegernsee, Germany. Dermatol Surg. 2004;30(5):709-717.
101. Tessari L. Nouvelle technique d'obtention de la sclero-mousse. Phlebologie. 2000;53-129.
102. Hamel-Desnos CM, Guias BJ, Desnos PR, Mesgard A. Foam sclerotherapy of the saphenous veins: randomised controlled trial with or without compression. Eur J Vasc Endovasc Surg. 2010;39(4):500-507.
103. Forlee MV, Grouden M, Moore DJ, Shanik GD. Stroke after varicose vein foam injection sclerotherapy. J Vasc Surg. 2006;43(1):162-164.
104. Eckmann DM, Kobayashi S, Li M. Microvascular embolization following polidocanol microfoam sclerosant administration. Dermatol Surg. 2005;31(6):636-643.
105. van den Bos RR, Milleret R, Neumann M, Nijsten T. Proof-of-principle study of steam ablation as novel thermal therapy for saphenous varicose veins. J Vasc Surg. 2011;53(1):181-186.
106. Eldor A. Thrombophilia, thrombosis and pregnancy. Thromb Haemost. 2001;86(1):104-111.
107. Thaler E, Huch R, Huch A, Zimmermann R. Compression stockings prophylaxis of emergent varicose veins in pregnancy. Swiss Med Wkly. 2001;131(45-46):659- 662.